Mouse Genome Editing Awards

Past Awardees

The Initiative supports awards for mouse genome editing with the objective of funding the generation of mouse models of human disease.

Mouse models of Stargardt disease for hypomorphs and modifiers

Rando Allikmets, PhD and Takayuki Nagasaki, PhD; Department of Opthalmology


Two different neurological diseases are caused by different mutations in the Pumilio1 gene

Vincenzo Genarrino, PhD; Department of Genetics & Development, Pediatrics and Neurology


Generation of mouse models of schizophrenia risk mutations in the SETD1A gene

Joseph Gogos, MD, PhD; Professor of Physiology and Cellular Biophysics, Neuroscience and Psychiatry (in the Mortimer B. Zuckerman Mind Brain Behavior Institute)


Murine models of FHOD3 mutations causing hypertropic and dilated cardiomyopathy

John P. Morrow, MD; Department of Medicine; Gregg G. Gundersen, PhD; Howard J. Worman, MD; Pathology and Cell Biology


Mouse model to establish the role of ARNT2 in the weight regulation pathway

Vidhu Thaker, MD; Department of Pediatrics


Precision SNP therapeutic Editing for Autosomal Dominant Retinitis Pigmentosa

Stephen Tsang, MD, PhD; Department of Ophthalmology

The supplemental funding for mouse models is made possible by the generous gift of Roy and Diana Vagelos, to the CPMI, and it is intended to support ground-breaking research in the field of precision medicine.

G protein signaling in a new neurodevelopmental disorder: A molecular and neuronal investigation of GNB1 Encephalopathy

David Goldstein, Professor, Director, Institute for Genomic Medicine


DDX10as a Precision Medicine target for the Acute Respiratory Distress Syndrome (ARDS)

Jahar Bhattacharya, MD, DPhil, Professor of Medicine Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine


Novel mouse models of human cardiomyopathy and skeletal myopathy based on a human FLNCc.7416_7418delGAA mutation”

Wendy K. Chung, MD, PhD, Kennedy Professor of Pediatrics; Carrie Welch, PhD, Assistant Professor of Medical Sciences


The role of the RNA binding protein Pumilio1 in two different neurological diseases

Vincenzo A. Gennarino, Ph.D., Genetics & Development, Pediatrics and Neurology

Awards funds to subsidize the creation of mouse models of human disease, using molecular tool, CRISPR/Cas9. Review process is complete and four proposals have been selected for funding.


Modeling HCN1 gene variants associated with human early infantile epileptic encephalopathy (EIEE) in mice

Jonathan Barasch, Professor of Medicine and Pathology and Cell Biology


A humanized mouse model to study the immunopathology of vitiligo.

Remi Creusot, PhD, Assistant Professor in the Department of Medicine and principal investigator at the Columbia Center for Translational Immunology and the Naomi Berrie Diabetes Center


Molecular Genetics of FTO.

Rudolph Leibel, Christopher J. Murphy Memorial Professor of Diabetes Research and Professor of Pediatrics and Medicine; Co-Director, Naomi Berrie Diabetes Center


Precision SNP Editing for Autosomal Dominant Retinitis

Stephen Tsang, MD, PhD, Associate Professor, Edward S. Harkness Eye Institute

Awards funds to subsidize the creation of mouse models of human disease, using molecular tool, CRISPR/Cas9. Review process is complete and five proposals have been selected for funding.


Modeling HCN1 gene variants associated with human early infantile epileptic encephalopathy (EIEE) in mice

Steven A. Siegelbaum, Professor and Chair, Department of Neuroscience


The role of Wdfy3 in CNS development and disease.

Ai amamoto, Ph.D., Department of Neurology


The Parkinson's disease associated GBA variant, E326K, as a therapeutic target

Lorraine N. Clark, Ph.D., Associate Professor and Assistant Medical Director, PCB, LPGM and Taub Institute for research on Alzheimer's disease and the aging brain


Mouse models of intellectual disability with novel lissencephaly associated with CRADD mutations

Carol M. Troy, MD, PhD, Professor of Pathology & Cell Biology


De novo truncating mutations in TRIM8 define a novel syndrome characterized by childhood epilepsy, focal segmental glomerulosclerosis (FSGS), and vesicoureteral reflux (VUR).

Simone Sanna-Cherchi, Florence Irving Assistant Professor of Medicine Paul Marks Scholar, Division of Nephrology - Columbia University College of Physicians and Surgeons